Buzz Stocks: Valeant Pharmaceuticals Intl Inc, Unilever plc (ADR), and TerraForm Global Inc

• VRX is up 5.1% at $24.74, after the Food and Drug Administration (FDA) approved the tablet form of Progenics Pharmaceuticals, Inc.'s (NASDAQ:PGNX) Relistor constipation treatment, to which VRX boasts exclusive development and commercialization rights. In addition, an FDA panel backed VRX's psoriasis drug, brodalumab, for FDA approval with a label warning of higher suicide risk, after six suicides that occurred during the drug's clinical trials. In addition, These are much-needed wins for the pharmaceutical stock, which has plunged nearly 90% year-over-year after a price gouging scandal and the ensuing backlash, with recent recovery attempts stalling at VRX's 50-day moving average -- a trendline set to be conquered today. Despite this, Valeant Pharmaceuticals Intl Inc has been a popular choice with bullish option players, with VRX's 50-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) of 2.02 sitting higher than 95% of all other readings from the past year. 

• UL is up 0.1% at $47.03, after the firm agreed to purchase Dollar Shave Club LLC, a subscription-based personal grooming company, for a reported $1 billion. Unilever plc (ADR) is up 9% year-to-date, hitting an all-time high of $48.29 earlier this month. In spite of these promising results, short interest in the stock has ballooned 40.8% over the last reporting period, although shorted shares still only account for a measly 0.1% of UL's float. Option players have been more bearish than usual ahead of Unilever earnings tomorrow, with UL's 10-day ISE/CBOE/PHLX put/call volume ratio of 1.83 sitting in the 76th percentile of its annual range.

• GLBL is up 12.3% at $3.65, after bankrupt Sunedison Inc announced its intent to sell its stake in the energy "yieldco." Since touching a record low of $1.92 in late March, GLBL has advanced roughly 90%. Short sellers could be getting nervous, with short interest up 33.9% over the past reporting period, and now accounting for 10.8% of TerraForm Global Inc's float -- an amount that would take just under a week to cover, at GLBL's average daily volume.

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check